These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 30839102)

  • 1. Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease.
    Maqsood U; Ho TN; Palmer K; Eccles FJ; Munavvar M; Wang R; Crossingham I; Evans DJ
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012930. PubMed ID: 30839102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD).
    Horita N; Goto A; Shibata Y; Ota E; Nakashima K; Nagai K; Kaneko T
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD012066. PubMed ID: 28185242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Once-daily long-acting beta₂-agonists/inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease.
    Sliwka A; Jankowski M; Gross-Sondej I; Storman M; Nowobilski R; Bala MM
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012355. PubMed ID: 30141826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).
    Ni H; Moe S; Soe Z; Myint KT; Viswanathan KN
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011594. PubMed ID: 30536566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis.
    Kew KM; Dias S; Cates CJ
    Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD010844. PubMed ID: 24671923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2-agonists (LABA) for adults with asthma.
    Kew KM; Evans DJ; Allison DE; Boyter AC
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011438. PubMed ID: 26031392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma.
    Kew KM; Dahri K
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011721. PubMed ID: 26798035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-acting beta2-agonists for chronic obstructive pulmonary disease.
    Kew KM; Mavergames C; Walters JA
    Cochrane Database Syst Rev; 2013 Oct; (10):CD010177. PubMed ID: 24127118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis.
    Oba Y; Keeney E; Ghatehorde N; Dias S
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012620. PubMed ID: 30521694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other long-acting muscarinic antagonist/long-acting β
    Siddiqui MK; Shukla P; Jenkins M; Ouwens M; Guranlioglu D; Darken P; Biswas M
    Ther Adv Respir Dis; 2019; 13():1753466619894502. PubMed ID: 31868101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma.
    Crossingham I; Turner S; Ramakrishnan S; Fries A; Gowell M; Yasmin F; Richardson R; Webb P; O'Boyle E; Hinks TS
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013518. PubMed ID: 33945639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Efficacy of Umeclidinium/Vilanterol Versus Other Bronchodilators for the Treatment of Chronic Obstructive Pulmonary Disease: A Network Meta-Analysis.
    Ismaila AS; Haeussler K; Czira A; Tongbram V; Malmenäs M; Agarwal J; Nassim M; Živković-Gojović M; Shen Y; Dong X; Duarte M; Compton C; Vogelmeier CF; Halpin DMG
    Adv Ther; 2022 Nov; 39(11):4961-5010. PubMed ID: 35857184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aclidinium bromide for stable chronic obstructive pulmonary disease.
    Ni H; Soe Z; Moe S
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD010509. PubMed ID: 25234126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease.
    Farne HA; Cates CJ
    Cochrane Database Syst Rev; 2015 Oct; (10):CD008989. PubMed ID: 26490945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indacaterol, a once-daily beta2-agonist, versus twice-daily beta₂-agonists or placebo for chronic obstructive pulmonary disease.
    Geake JB; Dabscheck EJ; Wood-Baker R; Cates CJ
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010139. PubMed ID: 25575340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
    Nannini LJ; Lasserson TJ; Poole P
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD006829. PubMed ID: 22972099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease.
    Janjua S; Fortescue R; Poole P
    Cochrane Database Syst Rev; 2020 May; 5(5):CD002309. PubMed ID: 32356609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β
    Ferguson GT; Darken P; Ballal S; Siddiqui MK; Singh B; Attri S; Holmgren U; de Nigris E
    Adv Ther; 2020 Jun; 37(6):2956-2975. PubMed ID: 32335859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma.
    Anderson DE; Kew KM; Boyter AC
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011397. PubMed ID: 26301488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination inhaled steroid and long-acting beta₂-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease.
    Rojas-Reyes MX; García Morales OM; Dennis RJ; Karner C
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD008532. PubMed ID: 27271056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.